Patents by Inventor Thomas Battersby

Thomas Battersby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10808244
    Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: October 20, 2020
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
  • Publication number: 20190203202
    Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 4, 2019
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
  • Patent number: 10273473
    Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.
    Type: Grant
    Filed: April 4, 2017
    Date of Patent: April 30, 2019
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
  • Publication number: 20170247753
    Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.
    Type: Application
    Filed: April 4, 2017
    Publication date: August 31, 2017
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
  • Patent number: 9719137
    Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: August 1, 2017
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
  • Patent number: 9695416
    Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: July 4, 2017
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
  • Publication number: 20160304951
    Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 20, 2016
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
  • Patent number: 9404154
    Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: August 2, 2016
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
  • Publication number: 20150152407
    Abstract: The present disclosure relates to normalization of biological samples, particularly samples comprising nucleic acids to be sequenced. The normalization protocols described herein may be utilized across multiple samples to cap total stoichiometric input and minimize variations in transcript abundance on a per-sample basis in a multiplexed fashion to dramatically increase the accuracy, capacity and efficiency of nucleic acid sequencing.
    Type: Application
    Filed: July 18, 2013
    Publication date: June 4, 2015
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Adrian Nielsen Fehr, Minxue Zheng
  • Publication number: 20140377755
    Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.
    Type: Application
    Filed: August 13, 2014
    Publication date: December 25, 2014
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
  • Patent number: 8685646
    Abstract: The methods and reagents described herein can be used to shorten incubation times in hybridization assays. As demonstrated in the examples, we have identified specific sulfonic acid polymers and hybridization conditions that lead to significantly shorter incubation times (e.g., signals after three hours that are comparable to signals that could traditionally only be obtained after overnight incubation). In some embodiments, shorter incubation times are achieved by adding the sulfonic acid polymer(s) during the hybridization process. Alternatively or additionally, in some embodiments, shorter incubation times are achieved via changes to the hybridizing conditions, e.g., by reducing the hybridization volume, increasing the salt concentration, andor increasing the probe concentration (capture extender probe andor label extender probe).
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: April 1, 2014
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Thomas Battersby, Mark Baumeister, Jesse Brooks, Felix Kleshik, Stacey Tam
  • Patent number: 8399194
    Abstract: The present invention relates to stable anti-parallel heteropolynucleotide duplexes, comprising a plurality of complementary purine-purine nucleobase dyads, wherein the nucleobase is coupled to a pentose sugar backbone. The present invention further relates to methods of hybridizing two heteropolynucleotide molecules to form such purine-purine nucleobase dyads, as well as kits and solid supports comprising such purine-purine nucleobase dyads.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: March 19, 2013
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Maria Albalos, Thomas Battersby, Edward Brooks, Michel Friesenhahn
  • Publication number: 20120142004
    Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.
    Type: Application
    Filed: May 19, 2010
    Publication date: June 7, 2012
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
  • Publication number: 20110236997
    Abstract: The methods and reagents described herein can be used to shorten incubation times in hybridization assays. As demonstrated in the examples, we have identified specific sulfonic acid polymers and hybridization conditions that lead to significantly shorter incubation times (e.g., signals after three hours that are comparable to signals that could traditionally only be obtained after overnight incubation). In some embodiments, shorter incubation times are achieved by adding the sulfonic acid polymer(s) during the hybridization process. Alternatively or additionally, in some embodiments, shorter incubation times are achieved via changes to the hybridizing conditions, e.g., by reducing the hybridization volume, increasing the salt concentration, and/or increasing the probe concentration (capture extender probe and/or label extender probe).
    Type: Application
    Filed: December 18, 2009
    Publication date: September 29, 2011
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Thomas Battersby, Mark Baumeister, Jesse Brooks, Felix Kleshik, Stacey Tam
  • Publication number: 20100190972
    Abstract: The present invention relates to stable anti-parallel heteropolynucleotide duplexes, comprising a plurality of complementary purine-purine nucleobase dyads, wherein the nucleobase is coupled to a pentose sugar backbone. The present invention further relates to methods of hybridizing two heteropolynucleotide molecules to form such purine-purine nucleobase dyads, as well as kits and solid supports comprising such purine-purine nucleobase dyads.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 29, 2010
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Thomas Battersby, Maria Albalos, Michel Friesenhahn, Edward Brooks